Press room

The project led by Dr. Anna Veiga, Group Leader of the Regenerative Medicine Program of the Bellvitge Biomedical Research Institute (IDIBELL) and director of Biology R&D of the Dexeus Mujer Reproduction Medicine Service, focused on the study of embryonic development through the CRISPR/Cas9 gene-editing technique, will receive funding from Merck Research Grants. A committee of experts has chosen Dr. Veiga's project from among the 18 presented in the Fertility category.

Barcelona already was a protagonist in assisted reproduction once. In 1984 the first test tube baby of Spain was born in Barcelona. Now, after 34 years, it keeps on being a protagonist as it is the destination of the so-called “reproductive tourism”, which moves to Catalonia every year thousands of women who want to become mothers. In order to meet this foreigners demand, the 33 authorised centres have a patient care service in several languages.

Early menopause, loss of ovarian function due to chemotherapy, removal of the ovaries, or advanced age are just some of the reasons why a woman may be physically unable to become a mother. Now, however, egg donation has changed the situation. This technique allows eggs to be transferred from one woman to another (donor and recipient): the donor egg is inseminated and implanted in the uterus of the recipient.

Surrogacy, better known as "womb for rent", is a matter that the Spanish government intends to address during this parliamentary term. This was announced by Spanish Minister of Justice, Rafael Catalá, who stated that sooner or later the government will have to begin to regulate this new social reality.

Women’s Health Dexeus launches a new online tool to be closer to you. We welcome Zoom Dexeus Woman, a newsletter that aims to catch up on the news from our centre, keep up to date with the latest developments we offer you and give information that may be interesting for you. We hope that you will find our proposals attractive!